Aeluma director granted 10,121 restricted shares

Denbaars Steven reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Denbaars Steven reported acquisition or exercise transactions in this Form 4 filing.

Aeluma, Inc. director Steven Denbaars reported an equity award of 10,121 shares of common stock in the form of restricted stock units at a stated price of $0.00 per share. Following this grant, his reported direct holdings total 395,209 shares of common stock.

The restricted stock units are scheduled to vest over several dates: approximately one-twelfth of the shares on December 31, 2025, one-quarter of the shares on March 31, June 30, and September 30, 2026, and the remaining one-sixth on November 30, 2026.

Insider Trade Summary

Grant/Award: 10,121 shares

Grant/Award 1 txn

Insider Denbaars Steven

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	10,121	$0.00	$0.00

Holdings After Transaction: Common Stock — 395,209 shares (Direct)

Footnotes (1)

1. F1. Restricted stock units scheduled to vest with respect to approximately 1/12 of the shares on December 31, 2025, 1/4 of the shares on March 31, June 30, and September 30, 2026, and 1/6 of the shares on November 30, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Aeluma (ALMU) report for Steven Denbaars?

Aeluma reported that director Steven Denbaars received a grant of 10,121 restricted stock units of common stock. The award was recorded at $0.00 per share and increased his directly held common stock position to 395,209 shares after the transaction.

Was the Aeluma (ALMU) insider transaction a stock purchase or an equity award?

The transaction for Steven Denbaars was an equity award, not an open-market stock purchase. It is classified as a grant or award acquisition of 10,121 restricted stock units of Aeluma common stock at a stated price of $0.00 per share.

How many Aeluma (ALMU) shares does Steven Denbaars hold after this Form 4 filing?

After the reported award, Steven Denbaars holds 395,209 shares of Aeluma common stock directly. This figure reflects his position following the grant of 10,121 restricted stock units disclosed in the Form 4 insider transaction.

What is the vesting schedule for Steven Denbaars’ Aeluma (ALMU) restricted stock units?

The 10,121 restricted stock units vest in stages: about one-twelfth on December 31, 2025, one-quarter on March 31, June 30, and September 30, 2026, and the remaining one-sixth on November 30, 2026, according to the Form 4 footnote.

Does the Aeluma (ALMU) Form 4 indicate any stock sales by Steven Denbaars?

The Form 4 does not report any stock sales for Steven Denbaars. It only shows an acquisition classified as a grant or award of 10,121 restricted stock units of common stock, with no shares disposed of in this filing.

What transaction code was used in the Aeluma (ALMU) Form 4 for Steven Denbaars?

The Form 4 uses transaction code “A” for Steven Denbaars’ activity. This code represents a grant, award, or other acquisition of securities, in this case 10,121 restricted stock units of Aeluma common stock awarded to the director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 04:54 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Denbaars Steven

(Last) (First) (Middle)

27 CASTILIAN DRIVE

(Street)

GOLETA CA 93117

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aeluma, Inc. [ ALMU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/03/2025		A		10,121(1)	A	$0	395,209	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock units scheduled to vest with respect to approximately 1/12 of the shares on December 31, 2025, 1/4 of the shares on March 31, June 30, and September 30, 2026, and 1/6 of the shares on November 30, 2026.

	/s/ Joshua L. Colburn, Attorney-in-Fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.